Skip to main content
PMC home page
Protein Science : A Publication of the Protein Society logoLink to Protein Science : A Publication of the Protein Society
. 1997 Jun;6(6):1284–1292. doi: 10.1002/pro.5560060616

Mapping of the plasminogen binding site of streptokinase with short synthetic peptides.

D Nihalani 1, G P Raghava 1, G Sahni 1
PMCID: PMC2143709  PMID: 9194188

Abstract

Although several recent studies employing various truncated fragments of streptokinase (SK) have demonstrated that the high-affinity interactions of this protein with human plasminogen (HPG) to form activator complex (SK-HPG) are located in the central region of SK, the exact location and nature of such HPG interacting site(s) is still unclear. In order to locate the "core" HPG binding ability in SK, we focused on the primary structure of a tryptic fragment of SK derived from the central region (SK143-293) that could bind as well as activate HPG, albeit at reduced levels in comparison to the activity of the native, full-length protein. Because this fragment was refractory to further controlled proteolysis, we took recourse to a synthetic peptide approach wherein the HPG interacting properties of 16 overlapping 20-mer peptides derived from this region of SK were examined systematically. Only four peptides from this set, viz., SK234-253, SK254-273, SK274-293, and SK263-282, together representing the contiguous sequence SK234-293, displayed HPG binding ability. This was established by a specific HPG-binding ELISA as well as by dot blot assay using 125I-labeled HPG. These results showed that the minimal sequence with HPG binding function resided between residues 234 and 293. None of the synthetic SK peptides was found to activate HPG, either individually or in combination, but, in competition experiments where each of the peptides was added prior to complex formation between SK and HPG, three of the HPG binding peptides (SK234-253, SK254-273, and SK274-293) inhibited strongly the generation of a functional activator complex by SK and HPG. This indicated that residues 234-293 in SK participate directly in intermolecular contact formation with HPG during the formation of the 1:1 SK-HPG complex. Two of the three peptides (SK234-253 and SK274-293), apart from interfering in SK-HPG complex formation, also showed inhibition of the amidolytic activity of free HPN by increasing the K(m) by approximately fivefold. A similar increase in K(m) for amidolysis by HPN as a result of complexation with SK has been interpreted previously to arise from the steric hinderance at or near the active site due to the binding of SK in this region. Thus, our results suggest that SK234-253 and SK274-293 also, like SK, bound close to the active site of HPN, an event that was reflected in the observed alteration in its substrate accessibility. By contrast, whereas the intervening peptide (SK254-273) could not inhibit amidolysis by free HPN, it showed a marked inhibition of the activation of "substrate" PG (human or bovine plasminogen) by activator complex, indicating that this particular region is intimately involved in interaction of the SK-HPG activator complex with substrate plasminogen during the catalytic cycle. This finding provides a rational explanation for one of the most intriguing aspects of SK action, i.e., the ability of the SK-HPG complex to catalyze selectively the activation of substrate molecules of PG to PN, whereas free HPN alone cannot do so. Taken together, the results presented in this paper strongly support a model of SK action in which the segment 234-293 of SK, by virtue of the epitopes present in residues 234-253 and 274-293, binds close to the active center of HPN (or, a cryptic active site, in the case of HPG) during the intermolecular association of the two proteins to form the equimolar activator complex; the segment SK254-273 present in the center of the core region then imparts an ability to the activator complex to interact selectively with substrate PG molecules during each PG activation cycle.

Full Text

The Full Text of this article is available as a PDF (1.9 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayley P. M., Findlay W. A., Martin S. R. Target recognition by calmodulin: dissecting the kinetics and affinity of interaction using short peptide sequences. Protein Sci. 1996 Jul;5(7):1215–1228. doi: 10.1002/pro.5560050701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beatty J. D., Beatty B. G., Vlahos W. G. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods. 1987 Jun 26;100(1-2):173–179. doi: 10.1016/0022-1759(87)90187-6. [DOI] [PubMed] [Google Scholar]
  3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  4. Dawson K. M., Marshall J. M., Raper R. H., Gilbert R. J., Ponting C. P. Substitution of arginine 719 for glutamic acid in human plasminogen substantially reduces its affinity for streptokinase. Biochemistry. 1994 Oct 11;33(40):12042–12047. doi: 10.1021/bi00206a005. [DOI] [PubMed] [Google Scholar]
  5. Deutsch D. G., Mertz E. T. Plasminogen: purification from human plasma by affinity chromatography. Science. 1970 Dec 4;170(3962):1095–1096. doi: 10.1126/science.170.3962.1095. [DOI] [PubMed] [Google Scholar]
  6. Fabian H., Naumann D., Misselwitz R., Ristau O., Gerlach D., Welfle H. Secondary structure of streptokinase in aqueous solution: a Fourier transform infrared spectroscopic study. Biochemistry. 1992 Jul 21;31(28):6532–6538. doi: 10.1021/bi00143a024. [DOI] [PubMed] [Google Scholar]
  7. Jackson K. W., Esmon N., Tang J. Streptokinase and staphylokinase. Methods Enzymol. 1981;80(Pt 100):387–394. doi: 10.1016/s0076-6879(81)80033-x. [DOI] [PubMed] [Google Scholar]
  8. Joseph G., Pick E. "Peptide walking" is a novel method for mapping functional domains in proteins. Its application to the Rac1-dependent activation of NADPH oxidase. J Biol Chem. 1995 Dec 8;270(49):29079–29082. doi: 10.1074/jbc.270.49.29079. [DOI] [PubMed] [Google Scholar]
  9. MARKUS G., WERKHEISER W. C. THE INTERACTION OF STREPTOKINASE WITH PLASMINOGEN. I. FUNCTIONAL PROPERTIES OF THE ACTIVATED ENZYME. J Biol Chem. 1964 Aug;239:2637–2643. [PubMed] [Google Scholar]
  10. Malke H., Roe B., Ferretti J. J. Nucleotide sequence of the streptokinase gene from Streptococcus equisimilis H46A. Gene. 1985;34(2-3):357–362. doi: 10.1016/0378-1119(85)90145-3. [DOI] [PubMed] [Google Scholar]
  11. Marder V. J. Recombinant streptokinase: opportunity for an improved agent. Blood Coagul Fibrinolysis. 1993 Dec;4(6):1039–1040. [PubMed] [Google Scholar]
  12. McClintock D. K., Bell P. H. The mechanism of activation of human plasminogen by streptokinase. Biochem Biophys Res Commun. 1971 May 7;43(3):694–702. doi: 10.1016/0006-291x(71)90670-x. [DOI] [PubMed] [Google Scholar]
  13. Misselwitz R., Kraft R., Kostka S., Fabian H., Welfle K., Pfeil W., Welfle H., Gerlach D. Limited proteolysis of streptokinase and properties of some fragments. Int J Biol Macromol. 1992 Apr;14(2):107–116. doi: 10.1016/0141-8130(92)90007-u. [DOI] [PubMed] [Google Scholar]
  14. Mohri H., Tanabe J., Katoh K., Okubo T. Identification of a novel binding site to the integrin alphaIIbbeta3 located in the C-terminal heparin-binding domain of human plasma fibronectin. J Biol Chem. 1996 Jun 28;271(26):15724–15728. doi: 10.1074/jbc.271.26.15724. [DOI] [PubMed] [Google Scholar]
  15. Nihalani D., Sahni G. Streptokinase contains two independent plasminogen-binding sites. Biochem Biophys Res Commun. 1995 Dec 26;217(3):1245–1254. doi: 10.1006/bbrc.1995.2902. [DOI] [PubMed] [Google Scholar]
  16. Parrado J., Conejero-Lara F., Smith R. A., Marshall J. M., Ponting C. P., Dobson C. M. The domain organization of streptokinase: nuclear magnetic resonance, circular dichroism, and functional characterization of proteolytic fragments. Protein Sci. 1996 Apr;5(4):693–704. doi: 10.1002/pro.5560050414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Radek J. T., Castellino F. J. Conformational properties of streptokinase. J Biol Chem. 1989 Jun 15;264(17):9915–9922. [PubMed] [Google Scholar]
  18. Radek J. T., Davidson D. J., Castellino F. J. Streptokinase-plasmin(ogen) activator assays. Methods Enzymol. 1993;223:145–155. doi: 10.1016/0076-6879(93)23042-l. [DOI] [PubMed] [Google Scholar]
  19. Reddy K. N., Markus G. Mechanism of activation of human plasminogen by streptokinase. Presence of active center in streptokinase-plasminogen complex. J Biol Chem. 1972 Mar 25;247(6):1683–1691. [PubMed] [Google Scholar]
  20. Reed G. L., Kussie P., Parhami-Seren B. A functional analysis of the antigenicity of streptokinase using monoclonal antibody mapping and recombinant streptokinase fragments. J Immunol. 1993 May 15;150(10):4407–4415. [PubMed] [Google Scholar]
  21. Reed G. L., Lin L. F., Parhami-Seren B., Kussie P. Identification of a plasminogen binding region in streptokinase that is necessary for the creation of a functional streptokinase-plasminogen activator complex. Biochemistry. 1995 Aug 15;34(32):10266–10271. doi: 10.1021/bi00032a021. [DOI] [PubMed] [Google Scholar]
  22. Robbins K. C., Summaria L., Wohl R. C. Human plasmin. Methods Enzymol. 1981;80(Pt 100):379–387. doi: 10.1016/s0076-6879(81)80032-8. [DOI] [PubMed] [Google Scholar]
  23. Shi G. Y., Chang B. I., Chen S. M., Wu D. H., Wu H. L. Function of streptokinase fragments in plasminogen activation. Biochem J. 1994 Nov 15;304(Pt 1):235–241. doi: 10.1042/bj3040235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Siefring G. E., Jr, Castellino F. J. Interaction of streptokinase with plasminogen. Isolation and characterization of a streptokinase degradation product. J Biol Chem. 1976 Jul 10;251(13):3913–3920. [PubMed] [Google Scholar]
  25. Welfle K., Pfeil W., Misselwitz R., Welfle H., Gerlach D. Conformational properties of streptokinase--differential scanning calorimetric investigations. Int J Biol Macromol. 1992 Feb;14(1):19–22. doi: 10.1016/s0141-8130(05)80014-5. [DOI] [PubMed] [Google Scholar]
  26. Wohl R. C. Interference of active site specific reagents in plasminogen-streptokinase active site formation. Biochemistry. 1984 Aug 14;23(17):3799–3804. doi: 10.1021/bi00312a002. [DOI] [PubMed] [Google Scholar]
  27. Wohl R. C., Summaria L., Robbins K. C. Kinetics of activation of human plasminogen by different activator species at pH 7.4 and 37 degrees C. J Biol Chem. 1980 Mar 10;255(5):2005–2013. [PubMed] [Google Scholar]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

RESOURCES